Lakshmikuttyamma A, Scott SA, DeCoteau JF, Geyer CR. 2009. Reexpression
of epigenetically silenced AML tumor suppressor genes by SUV39H1
inhibition. Oncogene 29: 576–588.
Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome.
Genome Biol 10: R25. doi: 10.1186/gb-2009-1 0-3-r25.
Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S,
Chen T, Li E, Jenuwein T, Peters AH. 2003. Suv39h-mediated histone H3
lysine 9 methylation directs DNA methylation to major satellite repeats
at pericentric heterochromatin. Curr Biol 13: 1192 –1200.
Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth
C, Payton JE, Baty J, Welch J, et al. 2010. DNMT3A mutations in acute
myeloid leukemia. N Engl J Med 363: 2424–2433.
Li H, Handsak er B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G,
Abecasis G, Durbin R. 2009. The Sequence Alignment/Map format and
SAMtools. Bioinformatics 25: 2078–2079.
Lindroth AM, Park YJ, McLean CM, Dokshin GA, Persson JM, Herman H,
Pasini D, Miro X, Donohoe ME, Lee JT, et al. 2008. Antagonism between
DNA and H3K27 methylation at the imprinted Rasgrf1 locus. PLoS Genet
4: e1000145. doi: 10.1371/journal.pgen.1000145.
Lister R, O’Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH,
Ecker JR. 2008. Highly integrated single-base resolution maps of the
epigenome in Arabidopsis. Cell 133: 523–536.
Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery
JR, Lee L, Ye Z, Ngo QM, et al. 2009. Human DNA methylomes at base
resolution show widespread epigenomic differences. Nature 462: 315–322.
Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-
Bourget J, O’Malley R, Castanon R, Klugman S, et al. 2011. Hotspots of
aberrant epigenomic reprogramming in human induced pluripotent
stem cells. Nature 471: 68–73.
Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D’Souza C, Fouse SD,
Johnson BE, Hong C, Nielsen C, Zhao Y, et al. 2010. Conserved role of
intragenic DNA methylation in regulating alternative promoters. Nature
466: 253–257.
Menendez L, Benigno BB, McDonald JF. 2004. L1 and HERV-W
retrotransposons are hypomethylated in human ovarian carcinomas.
Mol Cancer 3: 12. doi: 10.1186/1476-4598-3-12.
Moir RD, Montag-Lowy M, Goldman RD. 1994. Dynamic properties of
nuclear lamins:Lamin B is associated with sites of DNA replication. J Cell
Biol 125: 1201–1212.
Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE,
Boyle M, Woolcock BW, Kuchenbauer F, et al. 2010. Somatic mutations
altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas
of germinal-center origin. Nat Genet 42: 181–185.
Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J,
Perou CM, Szabo A, Bernard PS. 2007. Agreement in breast cancer
classification between microarray and quantitative reverse transcription
PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.
Clin Chem 53: 1273–1279.
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N,
Coppe JP, Tong F, et al. 2006. A collection of breast cancer cell lines for the
study of functionally distinct cancer subtypes. Cancer Cell 10: 515–527.
Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. 2008.
Agglomerative epigenetic aberrations are a common event in human
breast cancer. Cancer Res 68: 8616–8625.
Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.
2006. Estrogen-regulated genes predict survival in hormone receptor-
positive breast cancers. J Clin Oncol 24: 1656–1664.
Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S,
Fauron C, He X, Hu Z, et al. 2009. Supervised risk predictor of breast
cancer based on intrinsic subtypes. J Clin Oncol 27: 1160–1167.
Parkhomchuk D, Borodina T, Amstislavskiy V, Banaru M, Hallen L,
Krobitsch S, Lehrac h H, Soldatov A. 2009. Transcriptome analysis by
strand-specific sequencing of complementary DNA. Nucleic Acids Res 37:
e123. doi: 10.1093/nar/gkp596.
Parsons DW, Li M, Zhang X, Jones S, Lear y RJ, Lin JC, Boca SM, Carter H,
Samayoa J, Bettegowda C, et al. 2010. The genetic landscape of the
childhood cancer medulloblastoma. Science 331: 435–439.
Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman
W, Graf S, Flicek P, Kerkhoven RM, van Lohuizen M, et al. 2010.
Molecular maps of the reorganization of genome-nuclear lamina
interactions during differentiation. Mol Cell 38: 603–613.
Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone
M, Hansen H, Buys SS, Rasmussen K, et al. 2006. Classification and risk
stratification of invasive breast carcinomas using a real-time quantitative
RT-PCR assay. Breast Cancer Res 8: R23. doi: 10.1186/bcr1399.
Picard . 2011. http://picard.sourceforge.net.
Prak ET, Kazazian HH Jr. 2000. Mobile elements and the human genome. Nat
Rev Genet 1: 134–144.
Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou
CM. 2010. Phenotypic and molecular characterization of the claudin-
low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68. doi:
10.1186/bcr2635.
Pruitt KD, Tatusova T, Maglott DR. 2005. NCBI Reference Sequence (RefSeq):
A curated non-redundant sequence database of genomes, transcripts,
and proteins. Nucleic Acids Res 33: D501–D504.
Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito
ML, Segura I, Li X, Knevels E, et al. 2011. HRG inhibits tumor growth and
metastasis by inducing macrophage polarizatio n and vessel
normalization through downregulation of PlGF. Cancer Cell 19: 31–44.
Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G. 2010. Genome-wide
analysis of aberrant methylation in human breast cancer cells using
methyl-DNA immunoprecipitation combined with high-throughput
sequencing. BMC Genomics 11: 137. doi: 10.1186/1471-2164-11-137.
Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D,
Jenuwein T. 2004. A silencing pathway to induce H3-K9 and H4-K20
trimethylation at constitutive heterochromatin. Genes Dev 18: 1251–1262.
Schulz WA. 2006. L1 retrotransposons in human cancers. J Biomed Biotechnol
2006: 83672. doi: 10.1155/JBB/2006/83672.
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D,
Leary RJ, Ptak J, Silliman N, et al. 2006. The consensus coding sequences
of human breast and colorectal cancers. Science 314: 268–274.
Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT,
Stebbings LA, Leroy C, Edkins S, Mudie LJ, et al. 2009. Complex
landscapes of somatic rearrangement in human breast cancer genomes.
Nature 462: 1005–1010.
Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar
M. 1999. Thrombospondin-2: A potent endogenous inhibitor of tumor
growth and angiog enesis. Proc Natl Acad Sci 96: 14888–14893.
Tapia T, Smalley SV, Kohen P, Munoz A, Solis LM, Corvalan A, Faundez P,
Devoto L, Camus M, Alvarez M, et al. 2008. Promoter hypermethylation
of BRCA1 correlates with absence of expression in hereditary breast
cancer tumors. Epigenetics 3: 157–163.
Teer JK, Bonnycastle LL, Chines PS, Hansen NF, Aoyama N, Swift AJ, Abaan
HO, Albert TJ, Margulies EH, Green ED, et al. 2010. Systematic
compa
rison of three genomic enrichment methods for massively
parallel DNA sequencing. Genome Res 20: 1420–1431.
Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ,
Contino G, Deshpande V, Iafrate AJ, Letovsky S, et al. 2011. Aberrant
overexpression of satellite repeats in pancreatic and other epithelial
cancers. Science 331: 593–596.
Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: Discovering splice
junctions with RNA-Seq. Bioinformatics 25: 1105–1111.
Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ,
Salzberg SL, Wold BJ, Pachter L. 2010. Transcript assembly and
quantification by RNA-Seq reveals unannotated transcripts and isoform
switching during cell differentiation. Nat Biotechno l 28: 511–515.
van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C,
Edkins S, Hardy C, O’Meara S, Teague J, et al. 2009. Somatic mutations of
the histone H3K27 demethylase gene UTX in human cancer. Nat Genet
41: 521–523.
Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D,
Lin ML, Teague J, et al. 2011. Exome sequencing identifies frequent
mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
Nature 469: 539–542.
Volkel P, Angrand PO. 2007. The control of histone lysine methylation in
epigenetic regulation. Biochimie 89: 1–20.
Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM,
Van’t Veer LJ. 2005. Molecular portraits and 70-gene prognosis signature
are preserved throughout the metastatic process of breast cancer. Cancer
Res 65: 9155–9158.
Wild L, Flanagan JM. 2010. Genome -wide hypomethylation in cancer may
be a passive consequence of transformation. Biochim Biophys Acta 1806:
50–57.
Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM,
Barber T, Ptak J, et al. 2007. The genomic landscapes of human breast
and colorectal cancers. Science 318: 1108–1113.
Wu H, Coskun V, Tao J, Xie W, Ge W, Yoshikawa K, Li E, Zhang Y, Sun YE.
2010. Dnmt3a-dependent nonpromoter DNA methylation facilitates
transcription of neurogenic genes. Science 329: 444–448.
Yap DBJ, Chu T, Berg M, Schapira SW, Cheng A, Moradian RD, Morin AJ,
Mungall B, Meissner M, Boyle et al. 2010. Somatic mutations at EZH2 Y641
act dominantly through a mechanism of selectively altered PRC2 catalytic
activity, to increase H3K27 trimethylation. Blood 117: 2451–2459.
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC.
1998. Cloning, characterization, and chromosomal localization of
a gene frequently deleted in human liver cancer (DLC-1) homologous to
rat RhoGAP. Cancer Res 58: 2196–2199.
Received May 4, 2011; accepted in revised form September 26, 2011.
Hon et al.
258 Genome Research
www.genome.org
Cold Spring Harbor Laboratory Press on September 17, 2024 - Published by genome.cshlp.orgDownloaded from